EICHOR
● Recruiting
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors
Condition: Rectal Adenocarcinoma · Clinical Stage: Stage II (T3-4, N-) · Stage III (Any T, N+) · Sponsor: Memorial Sloan Kettering Cancer Center
About this study
The purpose of this study is to find out whether the study drug, TSR-042, followed by standard chemoradiotherapy (the chemotherapy drug capecitabine + radiation therapy) and standard surgery is an effective treatment for advanced dMMR solid tumors. The study will also look at the safety of the study drug.
This description comes directly from the study's public registry record.
Talk to the study team
Andrea Cercek, MD · 646-888-4189 · cerceka@mskcc.org
Neil Segal, MD, PhD · 646-888-4187
Always discuss trial participation with your own doctor first.
Locations (10)
| Hartford Healthcare (Data Collection) | Hartford, Connecticut, United States | Recruiting |
| Baptist Alliance MCI (Data Collection Only) | Miami, Florida, United States | Recruiting |
| Memorial Sloan Kettering Basking Ridge - Limited Protocol Activities | Basking Ridge, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Monmouth - Limited Protocol Activities | Middletown, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Bergen - Limited Protocol Activities | Montvale, New Jersey, United States | Recruiting |
| Memorial Sloan Kettering Commack - Limited Protocol Activities | Commack, New York, United States | Recruiting |
| Memorial Sloan Kettering Westchester - Limited Protocol Activities | Harrison, New York, United States | Recruiting |
| Memorial Sloan Kettering Cancer Center | New York, New York, United States | Recruiting |
| Memorial Sloan Kettering Nassau - Limited Protocol Activities | Uniondale, New York, United States | Recruiting |
| Lehigh Valley Health Network (Data Collection Only) | Allentown, Pennsylvania, United States | Recruiting |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04165772